» Articles » PMID: 11304828

Markers Close to the Dopamine D5 Receptor Gene (DRD5) Show Significant Association with Schizophrenia but Not Bipolar Disorder

Overview
Journal Am J Med Genet
Specialty Genetics
Date 2001 Apr 17
PMID 11304828
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Following the description of linkage of markers at chromosome 4p16 to bipolar disorder in several families [Blackwood et al., 1996], and the association of the alleles of a polymorphism closely linked to D5 dopamine receptor gene with schizophrenia [Williams et al., 1997], we have looked for linkage disequilibrium between a series of microsatellite markers from this region and major psychoses including schizophrenia, bipolar disorder, and unipolar major depressive disorder. A significant increase in the frequency of the 148 bp allele of DRD5 (P = 0.024) and the 244 bp allele of D4S615 (P = 0.001) was found in patients with schizophrenia (n = 158 DRD5; n = 133 D4S615), compared with patients with bipolar disorder (n = 270 DRD5; n = 107 D4S615), or controls without psychiatric illness (n = 437 DRD5; n = 309 D4S615). The frequency of the 148 bp allele of DRD5 was also increased in schizophrenia over unipolar major depressive disorder (n = 65). D4S615 was not typed in unipolar disorder. The estimated odds ratios confirmed that the 148 bp allele of DRD5 and the 244 bp allele of D4S615 conferred increased risk of schizophrenia. Estimated Haplotype (EH) analysis of 174 controls and 128 patients with schizophrenia who were typed for both markers confirmed the strong associations with these alleles but did not show evidence that the markers were in linkage disequilibrium with each other even though they lie approximately 150 kb apart. The data are consistent with an association between markers close to the D5 dopamine receptor and schizophrenia, but not bipolar disorder or unipolar major depression.

Citing Articles

Dopaminergic Epistases in Schizophrenia.

Bosun A, Albu-Kalinovic R, Neda-Stepan O, Bosun I, Farcas S, Enatescu V Brain Sci. 2024; 14(11).

PMID: 39595853 PMC: 11592377. DOI: 10.3390/brainsci14111089.


The dopamine receptor D gene shows signs of independent erosion in toothed and baleen whales.

Alves L, Alves J, Ribeiro R, Ruivo R, Castro F PeerJ. 2019; 7:e7758.

PMID: 31616587 PMC: 6791347. DOI: 10.7717/peerj.7758.


Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Gragnoli C, Reeves G, Reazer J, Postolache T Transl Psychiatry. 2016; 6:e785.

PMID: 27093067 PMC: 4872408. DOI: 10.1038/tp.2016.50.


Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.

Wang Z, Kemp D, Chan P, Fang Y, Ganocy S, Calabrese J Int J Neuropsychopharmacol. 2010; 14(1):131-42.

PMID: 20875219 PMC: 3433839. DOI: 10.1017/S146114571000101X.


SNP discovery and haplotype analysis in the segmentally duplicated DRD5 coding region.

Housley D, Nikolas M, Venta P, Jernigan K, Waldman I, Nigg J Ann Hum Genet. 2009; 73(Pt 3):274-82.

PMID: 19397556 PMC: 2749463. DOI: 10.1111/j.1469-1809.2009.00513.x.